Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging (Q43490722)

24 November 2017

title

Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging (English)

1 reference

24 November 2017

Guy J

1

1 reference

24 November 2017

Mao J

2

1 reference

24 November 2017

Bidgood WD Jr

3

1 reference

24 November 2017

Mancuso A

4

1 reference

24 November 2017

Quisling RG

5

1 reference

24 November 2017

publication date

1 May 1992

1 reference

24 November 2017

1 reference

24 November 2017

volume

99

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

713-719

1 reference

Gadolinium-DTPA-enhanced magnetic resonance imaging in optic neuropathies.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

1H NMR chemical shift selective (CHESS) imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Selective saturation NMR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Fat suppression with an improved selective presaturation pulse

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Optic neuritis and orbital lesions: lipid-suppressed chemical shift MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Magnetic resonance imaging of the optic nerve in optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Gadolinium-DTPA-enhanced magnetic resonance imaging in experimental optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Multiple sclerosis or blood-brain barrier disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

NMR studies in experimental allergic encephalomyelitis (EAE): normalization of T1 and T2 with parenchymal cellular infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

High resolution nuclear magnetic resonance imaging of the spinal cord in experimental demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Early detection of experimental allergic encephalomyelitis by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2892%2931892-5

7 January 2021

10.1016/S0161-6420(92)31892-5

Identifiers

DOI

1 reference

24 November 2017

1 reference